Brinker Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-13,049
Closed -$403K 949
2018
Q4
$403K Sell
13,049
-1,332
-9% -$48.6K 0.02% 659
2018
Q3
$545K Buy
14,381
+1,093
+8% +$41.3K 0.02% 691
2018
Q2
$510K Buy
13,288
+280
+2% +$9.44K 0.02% 701
2018
Q1
$439K Buy
+13,008
New +$499K 0.02% 747
2017
Q4
Sell
-4,885
Closed -$245K 998
2017
Q3
$245K Buy
+4,885
New +$250K 0.01% 864
2017
Q2
Sell
-6,379
Closed -$354K 825
2017
Q1
$354K Buy
6,379
+1,065
+20% +$58.7K 0.02% 722
2016
Q4
$277K Buy
+5,314
New +$256K 0.02% 600

Other funds holding PBH

Brinker Capital's PBH Position: Q1 2019 in Review

Brinker Capital sold out of Prestige Consumer Healthcare (PBH) in Q1 2019, closing a stake of 13,049 shares — an estimated $403K sold.

Brinker Capital first reported a position in PBH in Q4 2016 and held it in 7 quarters. The position peaked at $545K in Q3 2018. 221 funds tracked by Wall St. Rank hold PBH as of Q1 2019.

  • Brinker Capital reported no remaining Prestige Consumer Healthcare position as of Q1 2019 after selling out during the quarter.
  • Brinker Capital sold 13,049 Prestige Consumer Healthcare shares in Q1 2019, an estimated $403K.
  • Brinker Capital first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 7 quarters.
  • Brinker Capital's Prestige Consumer Healthcare position peaked at $545K in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2019.

Based on Brinker Capital's 13F filing for Q1 2019, filed 23 Apr 2019.